Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
04/23/2009 | WO2009052287A1 2 ' -flu0r0-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
04/23/2009 | WO2007144886A3 Virus-like particles for treatment of viral infections |
04/23/2009 | WO2007033080A3 Alzheimer's disease imaging agents |
04/23/2009 | WO2007002931A3 Phosphoramidate alkylator prodrugs |
04/23/2009 | US20090105468 Synthesis of Protected 3'-Amino Nucleoside Monomers |
04/23/2009 | US20090105186 Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases |
04/23/2009 | US20090105185 Nucleosides with anti-hepatitis B Virus activity |
04/23/2009 | US20090105184 Positron emission tomography probes for imaging immune activation and selected cancers |
04/23/2009 | DE102008050273A1 Vorrichtung und Verfahren zum Synthetisieren eines Biopolymers und Verfahren zum Wiedergewinnen eines Reagens zum Synthetisieren eines Biopolymers Apparatus and method for synthesizing a biopolymer and method for recovering a reagent for synthesizing a biopolymer |
04/23/2009 | CA2702274A1 2'-flu0r0-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors |
04/22/2009 | EP2050757A1 Method of producing 2' -deoxy-5-azacytidine (Decitabine) |
04/22/2009 | EP2049558A1 Naphthalene 2-carboxylate derivative useful for synthesizing gemcitabine and a method for preparing the same |
04/22/2009 | EP2049557A1 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors. |
04/22/2009 | EP1200455B1 Enzyme catalyzed therapeutic activation |
04/22/2009 | CN101415719A Methods of manufacture of 2 -deoxy-beta-L-nucleosides |
04/22/2009 | CN100480255C Partial and full agonists of AL adenosine receptors |
04/22/2009 | CN100480254C Synthesis method of 2-deoxy-beta-cytidine |
04/21/2009 | US7521432 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging |
04/21/2009 | US7521430 N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter |
04/21/2009 | US7521429 each case in free form or in salt form; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a method of controlling pests using those compositions are described.** Image-1 |
04/21/2009 | US7521235 Unique novel Bacillus thuringiensis gene with Lepidopteran activity |
04/16/2009 | WO2009047314A2 Method of producing nucleosides |
04/16/2009 | WO2009047313A2 Method of producing 2' -deoxy-5-azacytidine (decitabine) |
04/16/2009 | WO2006083937A3 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
04/16/2009 | WO2006066260A3 Compositions of and methods for producing phosphorus-chiral monomers and oligomers |
04/16/2009 | US20090099126 2'-C-(methyl-),2'-O-,3'-O-(benzylidene)<)adenosine; hepatitus C virus prodrugs ofpolymerase enzyme inhibitors; inhibition of HCV NS5B polymerase prevents formation ofthe double-stranded Hepitis C virus RNA; replication-defecctive; viral infections; Flaviviruses; picornavirus; rhinovirus; polio virus |
04/16/2009 | US20090099105 Content dependent inhibitors of cytidine deaminases and uses thereof |
04/16/2009 | CA2703560A1 Method of producing 2' -deoxy-5-azacytidine (decitabine) |
04/16/2009 | CA2701856A1 Method of producing nucleosides |
04/15/2009 | EP2048153A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
04/15/2009 | EP2048152A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
04/15/2009 | EP2048151A1 Method for producing nucleosides by direct glycosylation of the nucleoside base |
04/15/2009 | EP2048149A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
04/15/2009 | EP2046810A2 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products. |
04/15/2009 | EP2046346A1 Novel sglt inhibitors |
04/15/2009 | EP1003474B1 Method of treating dry eye disease with purinergic receptor agonists |
04/15/2009 | CN101410407A Substituted adenines and the uses thereof |
04/15/2009 | CN101410406A 6-modified bicyclic nucleic acid analogs |
04/15/2009 | CN101407534A 2'-fluoro-4'-substituted-nucleoside analogue and use thereof |
04/15/2009 | CN100478349C Nucleoside fluoride compound, its production and use |
04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
04/14/2009 | US7517646 Provides functional molecule having an affinity and specificity to a target comparable to the affinity and specificity of an antibody against an antigen; modified oligonucleotide sequence |
04/14/2009 | CA2221279C Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
04/09/2009 | WO2009044886A1 Process for production of ribofuranose derivatives |
04/09/2009 | WO2009044707A1 Nitrotriazole derivative and method for producing compound using the same |
04/09/2009 | WO2009043900A1 Drug transfer based on coenzyme a and acyl carrier protein |
04/09/2009 | WO2009043899A1 Drug transfer into living cells |
04/09/2009 | WO2009023855A3 Tetrahydropyran nucleic acid analogs |
04/09/2009 | WO2009006089A3 A2 adenosine receptor agonists |
04/09/2009 | US20090093623 4,7-dichlororhodamine dyes |
04/09/2009 | US20090093001 High content screening |
04/09/2009 | US20090092986 Nucleotide derivative for use in sequence determination of nucleic acid molecule; conjugate comprising fluorescent dye such as a xanthene dye, a rhodamine dye or a fluorescein; electrophoretic mobility; RNA or DNA sequencing |
04/09/2009 | US20090092981 Tetrahydropyran nucleic acid analogs |
04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
04/09/2009 | DE102008012336A1 Trennung von geladenen soluten durch elektrostatische Abstossungs-/hydrophile Interaktionschromatographie Absolute separation of charged electrostatic repulsion / hydrophilic interaction |
04/09/2009 | CA2707641A1 Process for producing ribofuranose derivatives |
04/08/2009 | EP2045258A1 3'-ethynylcytidine derivative |
04/08/2009 | EP2045257A1 Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
04/08/2009 | EP2045256A1 2'-cyanopyrimidine nucleoside compound |
04/08/2009 | EP2044070A1 Purine derivatives as a2a agonists |
04/08/2009 | EP2043653A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
04/08/2009 | CN101404883A Purine compounds and methods of use thereof |
04/08/2009 | CN101402662A Process for producing nelarabine |
04/08/2009 | CN100475833C Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
04/08/2009 | CN100475832C Novel highly-solid selectively synthesizing gemcitabine process and intermediate |
04/08/2009 | CN100475831C Synthesis of beta-l-2'-deoxy nucleosides |
04/08/2009 | CN100475753C Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
04/07/2009 | US7514568 Process for preparing substituted benzimidazole compounds |
04/07/2009 | US7514551 Multisignal labeling reagents, and processes and uses therefor |
04/07/2009 | CA2377147C New indolocarbazole alkaloids from a marine actinomycete |
04/07/2009 | CA2281133C Multiple-agents-binding compound and use thereof |
04/02/2009 | WO2009040269A1 Nucleoside derivatives as inhibitors of viral polymerases |
04/02/2009 | WO2009039639A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
04/02/2009 | WO2006073627A3 Vaccinia virus nucleic acids, polypeptides, and immunogenic compositions |
04/02/2009 | WO2004084453A3 METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES |
04/02/2009 | US20090087922 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
04/02/2009 | US20090087916 Assay method for identifying drug candidate |
04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
04/02/2009 | CA2700945A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
04/02/2009 | CA2700267A1 Azacytidine analogues and uses thereof |
04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
04/01/2009 | EP1126828B1 Oral administration of adenosine analogs |
04/01/2009 | CN101400688A Process for preparing L-nucleic acid derivatives and intermediates thereof |
04/01/2009 | CN101397316A Chemical synthesis method of ribavirin condensation compound |
03/31/2009 | US7511133 Sulfonamido derivatives with a conserved ethyl uronamide group;1-deoxy-1-[6-[[[[4-[N-(benzyl)aminosulfonyl]phenyl]amino]-carbonyl]amino]-9H-purin-9-yl]-N-ethyl- beta -D-ribofuranuronamide or derivatives; anticarcinogenic, antiinflammatory, antiischemic, antiepileptic, and hypertensive agents |
03/31/2009 | US7511125 Pyrimidine derivatives for labeled binding partners |
03/31/2009 | US7511027 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold |
03/31/2009 | US7510878 Bacillus thuringiensis gene with lepidopteran activity |
03/26/2009 | WO2009038548A1 Oligonucleotide probes and uses thereof |
03/26/2009 | WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use |
03/26/2009 | US20090082306 Deuterium-enriched telbivudine |
03/26/2009 | US20090082212 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
03/26/2009 | CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use |
03/25/2009 | EP1815022A4 Method of determining a cellular response to a biological agent |
03/25/2009 | CN101392012A Partial and full agonists of A1 adenosine receptors |
03/24/2009 | CA2421738C Purine ribosides as antiarrhythmics |
03/19/2009 | WO2009015446A3 Triazole derivatives as viral replication inhibitors |
03/19/2009 | WO2009012363A3 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
03/19/2009 | WO2008141248A3 Thiocarbon-protecting groups for rna synthesis |